Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Re...
Glass House Brands Q2 2026 gross margin slides as production costs rise, company says
Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
GLAS.A.U: Record production and NYSE uplisting position the company for growth amid regulatory shifts
Glass House Brands Q2 2026 adjusted EBITDA swings to profit of $5.7 million; revenue rises 64% q/q to $47 million
Glass House Brands schedules Q2 earnings call after market close
Glass House taps former DEA executive as adviser on Schedule III compliance for interstate cannabis trade, exports